NICE Grants Regulatory Approval for Expanded Use of Efient
The National Institute for Health and Care Excellence (NICE) have granted expanded regulatory approval for Eli Lilly/ Daiichi Sankyo’s bloodthinner Efient to help prevent atherothrombotic events. NICE published guidance endorsing Efient when given with aspirin, to avert blood clots in patients who either have had a heart attack, have unstable angina, or are undergoing percutaneous